Masimo Corporation

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 08/05/2024 am IST 5-day change 1st Jan Change
136 USD -1.45% Intraday chart for Masimo Corporation +1.18% +16.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set -- Shares Rise After Hours MT
Masimo Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024 CI
(MASI) MASIMO CORPORATION Forecasts Q2 Revenue Range $480M - $510M MT
(MASI) MASIMO CORPORATION Forecasts Fiscal Year 2024 EPS Range $3.54 - $3.70 MT
Earnings Flash (MASI) MASIMO CORPORATION Reports Q1 Revenue $492.8M, vs. Street Est of $487.7M MT
Transcript : Masimo Corporation, Q1 2024 Earnings Call, May 07, 2024
Masimo Obtains FDA Clearance for Over-The-Counter Version of Stork Baby Monitoring System MT
Masimo Receives FDA Clearance for Stork Over-the-Counter Baby Monitoring System CI
Masimo Insider Sold Shares Worth $5,446,616, According to a Recent SEC Filing MT
Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148 MT
Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban MT
Apple asks US appeals court to reverse Apple Watch import ban RE
Masimo Responds to Claims by Shareholder Activist Politan Capital MT
Masimo Responds to Politan Capital?s Nomination of Director Candidates CI
Masimo May Opt for Joint Venture to Spin Off Consumer Business MT
Masimo Corp Provides Information to the Shareholders CI
Sector Update: Health Care Stocks Decline Late Afternoon MT
Masimo May Opt for Joint Venture to Spin Off Consumer Business MT
Masimo May Reportedly Opt for Joint Venture to Split Off Consumer Business MT
Sector Update: Health Care Stocks Softer in Afternoon Trading MT
Sector Update: Health Care MT
Masimo Evaluating Potential Separation of Consumer Business; Activist Investor Nominates Board Candidates MT
Masimo Activist Investor Politan Capital Nominates 2 Board Candidates MT
Stifel Adjusts Price Target on Masimo to $148 From $125, Maintains Hold Rating MT
Sector Update: Health Care Stocks Steady Premarket Monday MT
Chart Masimo Corporation
More charts
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
136 USD
Average target price
150 USD
Spread / Average Target
+10.32%
Consensus
  1. Stock Market
  2. Equities
  3. MASI Stock
  4. News Masimo Corporation
  5. Masimo Posts Higher Q2 Earnings, Revenue; Issues Q3, Full-year Outlook
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW